#Histology And Cytology Market Analysis

[creativeera]

Histology And Cytology: An Overview of Microscopic Cell And Tissue Analysis Industry

Histology refers to the study of tissues at a microscopic level. It involves the examination of cell and tissue structure and how they are organised to form different body parts. Cytology is a sub-discipline of histology that focuses specifically on the microscopic evaluation of individual cells. Together, these fields provide crucial insights into normal and abnormal cellular structures and functions. Tools and Techniques Used in Histology Cytology A variety of tools and techniques are used by Histology And Cytology to examine cells and tissues. Light microscopes are essential for magnifying samples up to 1000x. Chemical staining helps distinguish between different tissue components by imparting specific colors like haematoxylin and eosin (H&E). Immunohistochemistry uses labeled antibodies to detect targeted proteins in situ. Enzyme histochemistry localizes enzyme activities in tissue slices. Electron microscopy such as transmission electron microscopy (TEM) provides ultrastructural details up to 200,000x magnification. Frozen sectioning rapidly prepares fresh tissue biopsies for histological evaluation. Collection techniques like fine needle aspiration biopsy (FNAB) extract cellular samples safely and accurately. Histological Examination of Tissues Histologists study tissue morphology to understand cellular architecture and specialization. Epithelial tissues that line and cover organs display characteristic shapes when squamous, cuboidal or columnar. Connective tissues composed of cells and extracellular matrix vary in density from loose areolar to dense regular tissues like bone. Muscle tissues exhibit repeating striations or spindle-like bundles of myofibrils. Nervous tissues have fibrous processes called neurons and neuroglia supporting cells. Examining normal tissue organization serves as a diagnostic baseline for comparison with pathological states. Cytological Evaluation of Bodily Fluids Histology And Cytology involves microscopically analyzing cells collected from various body fluids. Sputum screening diagnoses respiratory diseases via expectorated mucus samples. Urine cytology checks for abnormal or cancerous cells shed in urine which may indicate bladder or kidney problems. Cerebrospinal fluid cytology evaluates cells in CSF to help diagnose inflammatory versus infectious conditions of the brain and spinal cord. Serous cavity fluids from body cavities are also examined cytologically. Perhaps the most well-known application is Pap smear testing of cervical cells to detect pre-cancerous changes or cervical cancer at early treatable stages.

Get more insights on Histology And Cytology

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

[pranalip]

Histopathology Services Market  Detailed Market Research and Growth Factors | Global Insight Services

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.

View The Full Report Here –https://www.globalinsightservices.com/reports/histopathology-services-market

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

Market Trends and Drivers

Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. On the other hand, limitations associated with histopathology and immunohistochemistry is expected to restrain the overall market growth to a certain extent during the forecast period.

Market Restraints and Challenges

The disadvantages of histology and histological staining include: Preparation of the slides using the paraffin technique can be time-consuming; frozen slides are faster to prepare, but this can affect the resolution, especially when using light microscopy. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Subspecialisation in the diagnostic surgical pathology service and cytology; frozen sections; the autopsy; multidisciplinary team meetings; ancillary techniques; the pathology report and some other administrative duties.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10504

Global Histopathology Services Market Segmentation

By Type

Surgical Specimen

Breast Biopsy

Lung Biopsy

Renal Biopsy

Gastrointestinal Biopsy

Pancreatic Biopsy

Skin Tissue Biopsy

Testicular Biopsy

Others

By End-user

Diagnostic Laboratories and Reference Laboratories

Research Institutes

Others

Major Players in the Global Histopathology Services Market

The key players in the market are Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.

COVID-19 Impact:

At present, COVID-19 has made a major impact on the healthcare industry. Since the outbreak reached the U.S. in January 2020, hospitals, pharmacies, and other facilities have had to address challenges at a magnitude that had never been seen before. Moreover, according to a recent survey by Medscape in April 2020, substantial disruption have been witnessed in routine cancer care that includes tests for screening and diagnosis in suspected cases to their treatment as a result of the COVID-19 pandemic. The rapid increase in the number of infected patients in the US and Canada is likely to hamper the growth of histopathology services market and result in slowing down the market growth in the near future. Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10504

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[pranalipawarshinde]

Histopathology Services Market Trends and Forecast 2024-2033

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period.

View The Full Report Here –https://www.globalinsightservices.com/reports/histopathology-services-market

Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.

Market Trends and Drivers

Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Further, increasing government support to advance the smart technologies in preliminary diagnosis has led to robust development of histopathology services. Additionally, technology has played crucial in minimizing the complication of the manual process and advanced the existing histopathology technologies. Other factors like increasing public investments in advancing the histopathology services have fuelled the growth of the market. On the other hand, limitations associated with histopathology and immunohistochemistry is expected to restrain the overall market growth to a certain extent during the forecast period.

Market Restraints and Challenges

The disadvantages of histology and histological staining include: Preparation of the slides using the paraffin technique can be time-consuming; frozen slides are faster to prepare, but this can affect the resolution, especially when using light microscopy. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period. Subspecialisation in the diagnostic surgical pathology service and cytology; frozen sections; the autopsy; multidisciplinary team meetings; ancillary techniques; the pathology report and some other administrative duties.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS10504

Global Histopathology Services Market Segmentation

By Type

Surgical Specimen

Breast Biopsy

Lung Biopsy

Renal Biopsy

Gastrointestinal Biopsy

Pancreatic Biopsy

Skin Tissue Biopsy

Testicular Biopsy

Others

By End-user

Diagnostic Laboratories and Reference Laboratories

Research Institutes

Others

Major Players in the Global Histopathology Services Market

The key players in the market are Sonic Healthcare Limited; Laboratory Corporation of America Holdings; Acculabs Diagnostics UK Ltd; TPL Path Labs; UNILABS; Cureline Global Translational CRO; Targos; Cellular Pathology Services; Experimental Pathology Laboratories Inc (EPL); and CHARLES RIVER LABORATORIES, INC.. among others.

COVID-19 Impact:

At present, COVID-19 has made a major impact on the healthcare industry. Since the outbreak reached the U.S. in January 2020, hospitals, pharmacies, and other facilities have had to address challenges at a magnitude that had never been seen before. Moreover, according to a recent survey by Medscape in April 2020, substantial disruption have been witnessed in routine cancer care that includes tests for screening and diagnosis in suspected cases to their treatment as a result of the COVID-19 pandemic. The rapid increase in the number of infected patients in the US and Canada is likely to hamper the growth of histopathology services market and result in slowing down the market growth in the near future. Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS10504

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

[mitalipingale]

https://biiut.com/read-blog/49055_histology-and-cytology-market-analysis-size-share-and-forecast-2031.html

The Histology and Cytology Market in 2023 is US$ 18.59 billion, and is expected to reach US$ 58.34 billion by 2031 at a CAGR of 15.37%.

[naveendsw]

Histology And Cytology Market size, Share, Report 2030

The latest report by Precision Business Insights, titled “Histology and Cytology Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

[gauricmi]

Histology and Cytology Market: Advancements and Growing Demand

A) Market Overview:

The global Histology and Cytology Market is estimated to be valued at US$16,253.0 million in 2021 and is expected to exhibit a CAGR of 13.35% over the forecast period of 2021-2028. Histology and cytology are key branches of pathology that involve the study of cellular and tissue structures to diagnose diseases. These diagnostic techniques provide crucial insights for accurate diagnoses, prognosis, and personalized treatment plans. The market is driven by the increasing prevalence of chronic diseases, technological advancements, and the growing demand for precise diagnostic procedures.

B) Market Key Trends:

One key trend shaping the Histology and Cytology Market Growth is the adoption of automation in diagnostic laboratories. Automation helps in reducing errors, improving efficiency, and streamlining the diagnostic process. For example, automated staining platforms are widely used in histology laboratories for consistent and reliable results. These systems provide enhanced workflow efficiency and reduce turnaround time. The adoption of automation not only improves accuracy but also enables laboratories to handle a higher volume of samples, ultimately leading to improved patient care.

C) Porter's Analysis:

- Threat of New Entrants: The market faces a medium threat of new entrants due to the high initial investment required and the strict regulatory requirements for acquiring approvals for diagnostic tests.

- Bargaining Power of Buyers: Buyers, such as hospitals and diagnostic laboratories, have a moderate bargaining power since there are several market players offering similar products and services. However, the quality and reputation of the suppliers play a crucial role in their decision-making process.

- Bargaining Power of Suppliers: Suppliers of histology and cytology equipment and consumables have a moderate bargaining power. There are several suppliers in the market, providing a wide range of products. However, suppliers with established brand value and superior quality products may hold a higher bargaining power.

- Threat of New Substitutes: The threat of new substitutes is low in the Histology and Cytology Market. Histology and cytology techniques are essential for accurate disease diagnosis, and there are no effective substitutes available that can provide similar results.

- Competitive Rivalry: The market is highly competitive, with key players constantly focusing on product advancements and innovations to gain a competitive edge. The presence of established market players and the continuous introduction of new technologies intensify the competitive rivalry.

D) Key Takeaways:

1. Market Size: The global Histology and Cytology Market is expected to witness high growth, exhibiting a CAGR of 13.35% over the forecast period. The market's growth is driven by factors such as increasing chronic diseases, technological advancements, and the need for precise diagnostic procedures.

2. Regional Analysis: North America currently dominates the market, driven by advanced healthcare infrastructure, higher healthcare spending, and strong research and development activities. However, Asia Pacific is expected to witness the fastest growth, attributed to the rising awareness about early disease diagnosis, improving healthcare infrastructure, and increasing investments in diagnostic technologies.

3. Key Players: Key players operating in the global Histology and Cytology Market include Abbott, Hologic Inc., Becton, Dickinson and Company, Southwest Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck KGaA, Koninklijke Philips N.V., PerkinElmer, and Trivitron Healthcare. These players focus on strategic collaborations, mergers and acquisitions, and new product launches to strengthen their market position.

In conclusion, the Histology and Cytology Market is witnessing significant growth due to technological advancements, increasing chronic diseases, and the need for accurate diagnostic procedures. The market is characterized by the adoption of automation and increasing competition among key players. North America currently leads the market, but Asia Pacific is expected to be the fastest-growing region. Market players continuously strive to stay competitive through innovation and strategic partnerships.

[jean-perry]

https://www.marketwatch.com/press-release/global-histology-and-cytology-market-growth-size-and-manufacturers-analysis-research-report-and-forecast-2023-2030-by-vmreports-2023-03-12

[mrunalnerkarblog]

Cytology can be defined as the microscopic study of cell sample, which can be collected from any part of the body such as lungs, vagina, kidney, and others to assess the presence of irregular growth or lumps on the body surface. Cytology can also be used to assess abnormal body fluids that may accumulate in areas such as chest and abdomen region. The most common technique used to collect cytology cell sample is fine needle biopsy, which is also called fine needle aspiration wherein, a sterile needle attached to an empty syringe is inserted into the target tissue such as skin lump, joint, and others to aspirate either cells or body fluid.

[market-insight-2023]

Histology and Cytology Market Size, Status and Supply Forecast 2022 To 2030 - Abbott Laboratories, Becton Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd

This report on Histology and Cytology market by The Brainy Insights is an embracive analysis of the past trends & future opportunities in the given industry for the years 2022 to 2030. The global Histology and Cytology market report aids in evaluating statistics related to the industry's progress in terms of value (US$ Bn/Mn). The market research on Histology and Cytology will assist regulatory agencies and company leaders in making cost-effective, knowledgeable adjustments. The study comprises the most up-to-date practical advice & competitive data for other customers and firms looking to enter the regional or global Histology and Cytology market. The value chain investigation helps the customer accumulate information about the intermediaries of the worldwide Histology and Cytology market and various raw materials in providing value chain features & market price analysis. The report covers a discussion on the recent industry events & product innovations that is related to the market. The report utilizes PORTER's five forces for the power of competition, determination of entry barriers, and comparative analysis of buyer's & supplier's power, external & internal product substitution.

Get the inside scoop with Sample report @ https://www.thebrainyinsights.com/enquiry/sample-request/12506

Further, the companies are analyzed for both external and internal factors. The internal factors contain their manufacturing capabilities, research & development base, supply chain, customer base, labour force, availability of technologies, Histology and Cytology market share in specific regions, customer loyalty, the brand's value, etc. The external factors contain economic fluctuations, laws concerning product approval, the performance of the industry in specific regions, per capita income, and other socio-economic parameters. The key players are now focusing on executing strategies such as adopting new technology, M&A, alliances, product innovations, joint ventures, and partnerships. A PESTEL analysis is managed for the global Histology and Cytology market, providing valuable insights about the regional market. In addition, the SWOT analysis aims to determine the significant internal and external factors that may determine the failure or success of the customer's business venture. The strengths & weaknesses tend to be internal aspects as these are internal to the subject business. At the same time, threats & opportunities are often external factors, as these are in the environment external to the industry, for instance, the enterprise ventures of competitor firms.

The report also provides a comprehensive picture of the market by summating, synthesizing, and studying data from numerous sources by analyzing key parameters such as promotions, pricing, profit, and competition. The report thoroughly analyzes the related downstream & upstream industries, including raw materials suppliers, equipment manufacturers, industry analysts, traders, distributors, and consumers. The future trend of each segment has been presented in the global Histology and Cytology market attractiveness graph to provide a clear vision to the clients. The global Histology and Cytology market has contributed considerably to the parent industry and is booming for the international economy. The segments are further segmented into the sub-segments based on the sales & production of the product in the global Histology and Cytology market. The geographic presence of these organizations is highlighted to gain sound knowledge about the legal and economic parameters of the region.

Check complete table of contents with list of table and figures @ https://www.thebrainyinsights.com/report/histology-and-cytology-market-12506

The geographical segments of the report include: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy and Rest of Europe), Asia Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina, Colombia and Rest of South America), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of the Middle East and Africa)

The competitive analysis of the report consists of various players like Abbott Laboratories, Becton Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd, Hologic, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., Trivitron Healthcare., Southwest Precision Instruments, Merck KGaA, Allergan, Plc, Promega Corporation, Agilent Technologies Inc.

Type-based on a product classification in the industry contain: Histology, Cytology

Market applications can be fragmented as follows: Clinical Diagnostics, Molecular Diagnostics Study, Cell Signaling, Others

Have Any Query? Ask Our Expert @ https://www.thebrainyinsights.com/enquiry/request-customization/12506

About The Brainy Insights:

The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Avinash D

Head of Business Development

Phone: +1-315-215-1633

Email: sales@thebrainyinsights.com

Web: www.thebrainyinsights.com

[marketresearchreportsnews-blog]

Histology and Cytology Market Insights, Competitive Landscape and Forecast Report to 2026:Grand View Research, Inc.

Histology and Cytology Market Insights, Competitive Landscape and Forecast Report to 2026:Grand View Research, Inc.

San Francisco, 26 April , Histology and Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Cytology [Cervical Cancer, Breast Cancer], Histology), By Region, And Segment Forecasts, 2019 – 2026

The global histology and cytology market size is expected to reach USD 30.6 billion by 2026, based on a new report by Grand View Research, Inc. It is projected to expand at a CAGR…

[healthcare-market]

Histology & Cytology Market to Witness Exponential Growth by 2030

Histology & Cytology Market: Introduction

According to the report, the global histology & cytology market was valued at US$ 10.28 Bn in 2019 and is projected to expand at a CAGR of ~10% from 2020 to 2030. The global prevalence of cancer has been rising significantly, and the disease is considered the second major cause of death after cardiovascular diseases. Various factors contributing to the rise in the prevalence of cancer include urbanization, tobacco smoking, increasing pollution, changing diet patterns, and increase in the post-reproductive life span. According to the National Cancer Institute, over 1,806,590 new cases of cancer are anticipated to be diagnosed in the U.S. in 2020. Cervical cancer poses a significant threat to the female population in developing regions, and hence prevention as well as control of cervical cancer could be possible by early screening and diagnosis. Therefore, early detection of cervical cancer would improve the survival rate and quality of life of the patients, as it can be treated successfully with various treatment modalities. According to the World Health Organization (WHO), most of the cancer cases are detected in the final stage when they are not curable, especially in developing regions.

Request a Sample of Histology & Cytology Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2911

Cytology to Dominate Global Market

In terms of type of examination, the global histology & cytology market has been bifurcated into histology and cytology. The cytology segment has been split into cervical cancer, breast cancer, oral cancer, and others. The cytology segment dominated the market in terms of revenue in 2019. Increase in cases of cancer and rise in demand for diagnosis of the disease boost the growth of the segment.

Instruments & Analysis Software System to be in Demand

Based on product, the global histology & cytology market has been categorized into instruments & analysis software system and consumables & reagents. The instruments & analysis software system dominated the global histology & cytology market in 2019. Rise in product launch for various technologically advanced devices fuels the growth of the segment. However, the consumables & reagents segment is anticipated to expand at the highest CAGR during the forecast period.

Enquiry before Buying Histology & Cytology Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2911

Microscopy Methods to Lead Global Market

In terms of test type, the global histology & cytology market has been classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment has been segregated into cytochemistry & histochemistry and immunohistochemistry & immunofluorescence. The molecular genetic methods segment has been split into cytogenic tests, polymerase chain reaction, and others. The microscopy methods segment dominated the global histology & cytology market in 2019. Over the years, the prevalence of cancer has risen rapidly across the globe. According to GLOBOCAN, in 2018, the prevalence of cancer was 43.8 million globally (9.6 million cancer deaths were registered in the same year).

Hospitals and Clinics to be Major End User

Based on end user, the global histology & cytology market has been divided into hospitals & clinics, academic & research institutes, and others. The hospitals & clinics segment dominated the market in terms of revenue in 2019. Hospitals & clinics are especially meant only for detection of diseases. The availability of sophisticated instruments and favorable reimbursement policies for various treatments drive the segment.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2911

North America to Dominate Global Market

The global histology & cytology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2019, followed by Europe. North America accounted for a major share of the global histology & cytology market in 2019, owing to early adoption of advanced technologies and well-established healthcare infrastructure, and strategies adopted by key players. The histology & cytology market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030. Rise in prevalence of cancer across the region is projected to accelerate the growth of the market in the region.

Request for Analysis of COVID19 Impact on Histology & Cytology Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2911

Competition Landscape

Becton, Dickinson and Company, Danaher, and F. Hoffmann-La Roche Ltd. are the three major companies operating in the global histology & cytology market. The global histology & cytology market is fragmented in terms of number of players. Key players in the global market include Abbott, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, PerkinElmer, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare. New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate business in the global histology & cytology market.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/increase-in-smart-use-of-technology-demand-for-anti-ageing-facial-tools-to-boost-health-and-wellness-market-finds-tmr-301367166.html

https://www.prnewswire.co.uk/news-releases/continuous-r-amp-d-to-expand-therapeutic-use-of-platelet-rich-plasma-prp-in-regenerative-therapies-offer-profitable-opportunities-to-platelet-rich-plasma-market-players-global-market-valuation-to-reach-us-811-34-mn-by-2030-tmr-study-825481498.html

https://www.prnewswire.com/news-releases/dental-cements-market-to-be-worth-us-1-29-bn-by-2027--rising-prevalence-of-dental-carries-globally-to-fuel-expansion-of-market-says-tmr-301379450.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[mitalipingale]

The Histology and Cytology Market in 2023 is US$ 18.59 billion, and is expected to reach US$ 58.34 billion by 2031 at a CAGR of 15.37%.

[renubresearchanalysis]

Global Lung Cancer Diagnostics Market to Reach USD 3.6 Billion by 2027

According to Renub Research report titled “Lung Cancer Diagnostics Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Lung Cancer Diagnostics Market Size was USD 2.3 Billion in 2021. Lung cancer is the most typical cause of cancer-related mortality across the world. Smoking stays the predominant risk factor for lung cancer. Lung cancers are categorized histological into small and non–small cell lung cancers. The most common manifestation of lung cancer is dyspnea, cough, hemoptysis, and systemic symptoms such as weight loss and anorexia. These categories are used for treatment decisions and confining prognosis. The diagnostic evaluation of patients with presumed lung cancer includes tissue diagnosis; a complete staging work-up, including evaluation of metastases; and a functional patient evaluation.

Some Key Trends in the Lung Cancer Diagnostics Market:

As per WHO (World Health Organisation), in 2020, lungs cancer is the most frequently diagnosed (11.6% of all cases), followed by female breast (11.6%) and colorectal cancers (10.2%).

Globally, the adoption of advanced multimodal diagnostic approaches heavily influences lung cancer diagnosis. For instance, liquid biopsy and breath analysis developments are the most promising and advanced technologies for detecting biomarkers associated with lung cancer.

AI and Wearable devices are two niche areas that require development and standardization for commercialization. The upcoming technology based on nano-systems includes robots, fibers, and particles for sensitive detection of lung cancer.

Soon, nanotechnology-based theranostics, aptamers, and MIPs will occur in the early-stage diagnosis of lung cancer. These trends boost the demand for lung cancer diagnostics attributed to their laid-back usage and comparatively reduced cost.

For Lung Cancer Diagnosis Imaging Tests are the Primary Screening Techniques

Over the years, test types such as Imaging Test, Biopsy, Sputum Cytology, Molecular Test, and Others have become suitably placed diagnostic in lung cancer. The imaging tests segment was recognized as the most significant test segment due to the high usage rates of various imaging techniques, including CT scan MRI and X-ray, as the primary screening techniques used for lung cancer diagnosis. Imaging tests perform as the initial screening tool for lung cancer diagnosis and are helpful throughout the treatment period. Further, molecular tests about lung cancer facilitate personalized treatments. These tests are utilized to identify genes, specific proteins,  and other tumor-specific factors known as mutations, including ALK, EGFR, BRAF,  ROS1, HER2, and RET.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=lung-cancer-diagnostics-market-p.php

Worldwide Lung Cancer Diagnostics Industry will grow with a CAGR of 7.75% from 2021-2027

Besides, the lung cancer diagnostic market is segmented into Small-cell Lung Cancer Diagnostics and Non-Small-cell Lung Cancer Diagnostics. Small cell lung cancer spreads quickly in the body, making detecting this cancer at an early-stage difficult. However, people with non-small cell lung cancer can be treated with surgery, chemotherapy, radiation therapy, targeted therapy, or a combination of these treatments. Various subtypes of NSCLC include Adenocarcinoma, Squamous Cell Carcinoma, Large cell carcinoma, and other less frequent NSCLCs.

Along with this, Hospitals & Clinics, Diagnostic Centers, and Research institutes remain the most lucrative end-users of lung cancer diagnostics in the global market. There is a massive demand for lung cancer diagnostic in hospitals & clinics due to the rising number of patients visiting hospitals, the increasing number of in-house diagnostic procedures performed in hospitals, and cumulative awareness regarding early diagnosis.

Worldwide Rising Prevalence of Lungs Cancer in 2021:

As per the American Cancer Society’s for lung cancer in the United States, 235,760 new cases of lung cancer (116,660 in women and 119,100 in men) and 131,880 deaths from lung cancer (62,470 in women and 69,410 in men)

As per Japanese times, 130,000 people in Japan contract lung cancer every year.

According to LuCE, more than 310,000 adults all over Europe were diagnosed with lung cancer.

COVID-19 Impact:

With the outbreak of the COVID-19, the lung cancer diagnostic market has had a significant setback in terms of growth. As the COVID-19 cases grew, the healthcare system turned its focus in curbing the disease, resulting in the delay of diagnosis and treatment of other chronic conditions like cancer. Thus, the pandemic scenario harms the lung cancer diagnostics industry.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/lung-cancer-diagnostics-market-p.php

Competitive Landscape:

Prominent players such as Illumina, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc, QIAGEN N.V., and Roche Holding AG embrace innovative approaches such as ground-breaking marketing tactics and technological advances for cancer screening mergers and acquisitions.

Market Summary:

Diagnosis Test Type – Our Report covered by Diagnosis Test Type in the 5 viewpoints (Imaging Test, Biopsy, Sputum Cytology, Molecular Test and Others)

Lung Cancer Type – Renub Research Report covers by Lung Cancer Type in the 2 viewpoints (Small-cell Lung Cancer Diagnostics and Non-Small-cell Lung Cancer Diagnostics)

Non-Small- cell Lung Cancer Diagnostics – This Report covers by Non-Small-cell Lung Cancer Diagnostics into 4 viewpoints (Adenocarcinoma, Squamous Cell Carcinoma, Large cell carcinoma and others and not otherwise specified)

End-User – We have covered Global Lung Cancer Diagnostics Market by End-User in the 4 viewpoints (Hospitals & Clinics, Diagnostic Centers, Research Institute and Others)

Region- This Report covers Global Lung Cancer Diagnostics Market breakup by 4 Regions (North America, Europe, Asia Pacific and Rest of World)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Illumina, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc, QIAGEN N.V. and Roche Holding AG

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

[karishmamulani]

Histology and Cytology Market Detailed Analytical Overview By 2028

Histology and Cytology Market Detailed Analytical Overview By 2028

The global histology and cytology market size is expected to reach USD 37.08 billion by 2028 according to a new study by Polaris Market Research. The report “Histology and Cytology Market Share, Size, Trends, Industry Analysis Report, By Examination Type (Histology, Cytology); By Product (Instrument & Analysis Software System, Consumables & Reagents); By End-Use (Life Sciences, Clinical…

[industry365]

Histology and Cytology  Market Size, Share, Growth and Industry Forecast By 2028

The global histology and cytology market size is expected to reach USD 37.08 billion by 2028 according to a new study by Polaris Market Research. The report “Histology and Cytology Market Share, Size, Trends, Industry Analysis Report, By Examination Type (Histology, Cytology); By Product (Instrument & Analysis Software System, Consumables & Reagents); By End-Use (Life Sciences, Clinical Diagnostics); By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Histology is a branch of biology that deals with the microscopic analysis of tissues for the diagnosis of chronic disorders mainly in cancer and also in other conditions such as autoimmune disorders and infections. Histology involves tissue preparation, tissue staining, hybridization, and microscopy. Whereas, cytology is a branch of biology that deals with the microscopic analysis of cells for the diagnosis of various chronic disorders.

Virtual microscopy is one of the most significant market developments in microscopy and immunohistochemistry, and it is estimated to drive market demand for histology and cytology tests. Users can create virtual slides, which can then be stored on a network server and accessed by other users via virtual microscopy.

Get sample copy: https://www.polarismarketresearch.com/industry-analysis/histology-cytology-market/request-for-sample

The increasing incidence of cancer globally is the main driving force for the market growth of the histology and cytology. Every year, more than 19 million cancer cases are diagnosed worldwide, and the most common type of cancer is breast cancer, which is diagnosed in more than 2 million people every year. Cancer is an emerging healthcare problem in Africa and South Africa could see an estimated increase of 78% cancer cases, by 2030.

The emergence of digital platforms powered by AI along with new product launches and acquisitions is expected to drive the global market for histology and cytology during the forecast period. ONCORE Pro, an automated staining system was launched by Biocare Medical, LLC in January 2021 that has applications in Immunohistochemistry (IHC). ONCORE Pro System can process 36 slides simultaneously that will help in-vitro diagnostic labs to improvise their throughput of sample processing.

Mosaic Laboratories that offer histology services was acquired by Caprion-HistoGeneX in January 2021. The acquisition will help Caprion-HistoGeneX to improve its services in histopathology biomarker analysis for clinical trials. Mosaic is specialized in multiplex IHC with spectral imaging, and it has well-proven capabilities to support exploratory biomarker analysis services for clinical and preclinical trials.

Market Participants such as Roche Ltd., Thermo Fisher Scientific, Inc., Hologic, Inc., Becton, Dickinson & Company, Merck KGaA, Danaher Corporation, Abbott, Sysmex Corporation, Koninklijke Philips N.V., and Trivitron Healthcare are some of the key players operating in the global market.

Get discount offer: https://www.polarismarketresearch.com/industry-analysis/histology-cytology-market/request-for-discount-pricing

Polaris Market Research has segmented the histology and cytology market report on the basis of type of examination, product, end-users, and region:

Histology and Cytology, Examination Type (Revenue – USD Million, 2016 – 2028)

Histology

Cytology

By Technique

Microscopy

Immunohistochemistry

Molecular pathology

Cryostat & Microtomy

By Technique

By Application

Microscopy

Immunohistochemistry

Molecular pathology

Cryostat & Microtomy

Cervical Cancer

Breast Cancer

Bladder CancerLung Cancer

Other Cancers

Histology and Cytology, Product Outlook (Revenue – USD Million, 2016 – 2028)

Instruments and Analysis Software System

Consumable and Reagents

Histology and Cytology, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

Life Sciences

Clinical Diagnostics

Histology and Cytology, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

France

Germany

UK

Italy

Spain

Netherlands

Austria

China

Japan

India

South Korea

Malaysia

Indonesia

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

UAE

South Africa

Buy Now: https://www.polarismarketresearch.com/checkouts/8701